Recently, researchers have also found that PAD1 inhibitors could also inhibit tumor growth and metastasis through the MEK1–ERK1/2–MMP2 pathway [44], and PAD3 inhibitors could kill PAD3-expressing HEK293T cells by rescue of thapsigargin-induced cell death [45]. This evidence concerns the gene PADI3 and neoplasm.